Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 13, 2025 • 12:51 PM ET

Date/Time Source News Release
08/05/2025 08:32 AM EDT GlobeNewswire Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
07/16/2025 08:45 AM EDT GlobeNewswire Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
07/07/2025 08:15 AM EDT GlobeNewswire Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
06/25/2025 08:38 AM EDT GlobeNewswire Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
06/11/2025 09:00 AM EDT GlobeNewswire Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
06/05/2025 09:15 AM EDT GlobeNewswire Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
05/21/2025 08:55 AM EDT GlobeNewswire Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
05/16/2025 04:15 PM EDT GlobeNewswire Silo Pharma Announces Closing of $2 Million Public Offering
05/14/2025 04:07 PM EDT GlobeNewswire Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15
05/14/2025 08:40 AM EDT GlobeNewswire Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories
Page

Additional News

As of August 13, 2025 • 12:51 PM ET

Date/Time Source News Release
08/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, August 12th, 2025
08/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Silo Pharma Inc.
07/07/2025 09:32 AM EDT InvestorWire InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Expects SPC-15 PTSD Study Results Within 90 Days 
06/25/2025 11:00 AM EDT SeekingAlpha Silo Pharma to form JV with Hoth Therapeutics for obesity treatment
06/11/2025 11:09 AM EDT PsychedelicNewsWire PsychedelicNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
06/05/2025 09:45 AM EDT SeekingAlpha Silo Pharma approves purchase of Bitcoin as treasury reserve asset; shares up
05/21/2025 09:55 AM EDT InvestorWire InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with Nasal Spray Device Study for SPC-15
05/21/2025 09:46 AM EDT SeekingAlpha Silo Pharma teams up with Resyca for IND-supporting intranasal drug-device study of PTSD drug
05/19/2025 09:05 AM EDT InvestorWire InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
05/16/2025 09:15 AM EDT InvestorWire InvestorNewsBreaks - Silo Pharma Inc. (NASDAQ: SILO) Prices $2 Million Public Offering of Common Stock and Warrants
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.